stock-detail (GALE)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

TESARO Submits New Drug Application for Intravenous Rolapitant to the U.S. Food and Drug Administration

3/14/2016 11:03 am

(StreetInsider) Mar 14, 2016 - TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has submitted the New Drug Application (NDA) for an intravenous (IV) formulation of rolapitant to the U.S. Food and Drug Administration (FDA).

AACR Supports Obama Administration's Commitment to More Federal Funding to Fight Cancer

2/2/2016 12:01 pm

(AACR) Feb 1, 2016 - Group stands ready to work with Vice President Biden's "Cancer Moonshot Task Force”.

If Cancer Becomes Biden’s Cause, a Bold but Polarizing Doctor Is On Call

11/2/2015 12:01 pm

(New York Times) Nov 1, 2015 - One day last winter, desperate as his son fought for his life against a killer brain cancer, Vice President Joseph R. Biden Jr. and his family reached out to one of America’s most famous, and controversial, doctors for help.

Merck CEO Says Drug-Price Debate Doesn't Account for R&D Risks

11/2/2015 12:01 pm

(Bloomberg) Oct 30, 2015 - Talking drug prices with President Barack Obama was just the start. Merck & Co.’s chief executive officer says he’s on a campaign to change a perception most Americans have: that pharmaceutical companies charge too much for their drugs.

Drug Makers Buy Pricey Vouchers to Speed Products to Market

11/2/2015 12:01 pm

(Wall Street Journal) Nov 1, 2015 - AbbVie, Sanofi are among those paying large sums for ‘priority review’ at FDA.

ASCO-AACI Launch Survey to Assist Researchers in Managing Clinical Trials; Survey Closes November 15

11/2/2015 12:00 pm

(ASCO in Action) Nov 1, 2015 - On November 1, ASCO and the Association of American Cancer Institutes (AACI) launched a survey to assess administrative and/or regulatory burdens associated with conducting and managing clinical trials.

ASCO Commends FDA for First-Ever No-Tobacco-Sale Order

11/2/2015 12:00 pm

(ASCO in Action) Oct 30, 2015 - The U.S. Food and Drug Administration (FDA) recently initiated the first-ever No-Tobacco-Sale Order (NTSO) actions for a group of retailers who have repeatedly violated certain restrictions on the sale and distribution of tobacco products, including sales to minors.

Loss of Insurance Plans Could Devastate Cancer Patients

11/2/2015 12:00 pm

(Houston Chronicle) Oct 31, 2015 - As the health insurance enrollment season opens Sunday, it's what missing from the list of options that frightens Martha Gardenier most.

Statement from American Society of Hematology President David A. Williams, MD, on Passage of the Bipartisan Budget Act of 2015

11/2/2015 12:00 pm

(ASH) Oct 30, 2015 - Early this morning, the Senate passed the Bipartisan Budget Act of 2015, a compromise between Congress and the White House that will provide relief from harmful sequestration cuts for the next two years.

Foundation Medicine Announces Roche Pharmaceuticals (Israel) Ltd. to Commence Commercial Activities in Support of its Molecular Information Products in Oncology

11/2/2015 12:00 pm

(TheStreet) Nov 2, 2015 - Israel selected as the first ex-US launch country for Foundation Medicine’s products.

Merck and Selvita Announce Drug Discovery Collaboration

11/2/2015 12:00 pm

(Selvita) Nov 2, 2015 - Focus is to discover small molecule lead candidates for multiple oncology indications.

OSE Pharma Receives Positive Opinion From Several European Countries To Start Pivotal Phase 3 Trial of Tedopi®

11/2/2015 12:00 pm

(OSE Pharma SA) Nov 2, 2015 - OSE Pharma SA, an immuno-oncology company developing a T-specific immunotherapy for late-stage cancer patients, announces that the regulatory authorities in 7 European countries have issued a positive opinion to initiate its pivotal Phase 3 clinical trial of Tedopi® for patients diagnosed with advanced non-small cell lung cancer (NSCLC).

SERMO Poll: 72% of Doctors Support Prophylactic Surgery for Women with BRCA Mutations

11/2/2015 12:00 pm

(SERMO) Oct 30, 2015 - Doctors do not support universal testing for BRCA gene mutations.

LUNGevity's New Online Tool Empowers Patients to Find and Enroll in Clinical Trials

11/2/2015 12:00 pm

(LUNGevity) Nov 2, 2015 - LUNGevity has joined forces with Lilly Oncology to develop an online tool that streamlines the process and eases navigation of clinical trial searches.

Loughborough University Unveils World’s First Lab-In-A-Briefcase

11/2/2015 11:05 am

(Loughborough University [UK]) Oct 30, 2015 - Academics at Loughborough University hope to boost early detection rates of cancer in developing countries with their portable lab-in-a-briefcase that can operate even at high temperatures.

ACCC Advocacy Alert: Budget Deal Includes New Outpatient Reimbursement Policy

11/2/2015 11:05 am

(ACCC Advocacy Alert) Oct 30, 2015 - This week, the U.S. House of Representatives proposed a policy as part of a broader budget deal that would lower reimbursement rates for services provided at newly acquired provider-based (PBD) off-campus hospital outpatient departments (HOPDs).

CMS Releases Three Final Rules: 2016 Medicare Physician Fee Schedule, 2016 Hospital Outpatient Prospective Payment System, and Medicaid Rule Addressing Access to Covered Services

11/2/2015 11:05 am

(ASCO in Action) Oct 30, 2015 - This afternoon, the Centers for Medicare & Medicaid Services (CMS) released its final rule on the 2016 Medicare Physician Fee Schedule.

MD Anderson Regains Top Cancer-Care Ranking

7/21/2015 12:00 pm

(Houston Chronicle) July 20, 2015 - M.D. Anderson Cancer Center has regained the No. 1 designation for cancer care in U.S. News & World Report's annual rankings of hospitals, a year after a drop to No. 2 ended seven straight years atop the list.

Appeal Court Clears Inspectors In French Breast Implants Case

7/2/2015 11:04 am

(Reuters) July 2, 2015 - A French appeal court on Thursday overturned a negligence conviction against certification agency TUV Rheinland for its role in approving faulty breast implants produced with counterfeit silicone by manufacturer PIP until its 2010 closure.

'Trip Wire': UPMC Says It Cut Highmark Members After Insurer Stopped Paying Higher Rates For Cancer Treatment

5/28/2015 12:04 pm

(Pittsburgh Business Times) May 27, 2015 - UPMC decided to deny some 182,000 Highmark Medicare Advantage plan members in-network access to its doctors and hospitals after the health insurer last year said it would not pay UPMC higher rates for administering cancer–fighting drugs, a lawyer for the hospital giant argued Wednesday morning.

UVM Biostatistician Helps FDA Approve First Biosimilar Drug

4/8/2015 12:00 am

(University of Vermont) Apr 8, 2015 - Since 2013, Cole has sat on an important FDA panel that assesses applications for new cancer medications and makes recommendations to the federal agency.

Bristol-Myers Squibb's $1.6 Billion On New Drug Deals Is Well Spent

3/4/2015 12:02 pm

(Forbes) Mar 3, 2015 - Bristol-Myers Squibb recently entered a couple of agreements worth $1.6 billion to bolster its immuno-oncology drugs portfolio.

Merck Announces Positive Study Investigating the Use of KEYTRUDA® (pembrolizumab) Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma

11/17/2014 05:01 am

(CNBC) Nov 16, 2014 - KEYTRUDA demonstrated superiority to chemotherapy for primary endpoint of progression-free survival; findings presented for first time at Society of Melanoma Research (SMR) 2014 International Congress.

Auxilium Adds Poison Pill Against Endo's $2.2B Offer

9/17/2014 07:02 am

(Bloomberg) Sept 17, 2014 - Auxilium Pharmaceuticals Inc. adopted a so-called poison pill shareholder rights plan to try and fend off an unsolicited, $2.2 billion offer from Endo International Plc, a maker of pain drugs.

ALTTO Fallout Focuses Debate on the Meaning of pCR

7/30/2014 06:04 am

(Medscape Medical News) July 29, 2014 - This summer, results from the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) trial sparked a controversy that is gathering momentum.